Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

236.22
+6.923.02%
Post-market: 236.480.2586+0.11%19:58 EDT
Volume:1.91M
Turnover:449.27M
Market Cap:31.52B
PE:42.04
High:238.97
Open:228.88
Low:228.34
Close:229.30
52wk High:495.55
52wk Low:197.81
Shares:133.43M
Float Shares:133.16M
Volume Ratio:1.16
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.62
EPS(LYR):2.33
ROE:96.55%
ROA:12.34%
PB:23.28
PE(LYR):101.38

Loading ...

Movement Alert|Alnylam Pharmaceuticals Rises 5.47% in Regular Trading, Multiple Institutions Call Prior 28% Selloff Overdone

Market Focus
·
Aug 03

Alnylam Pharmaceuticals is Maintained at Overweight by Barclays

Dow Jones
·
Aug 03

Alnylam price target lowered to $450 from $527 at Barclays

TIPRANKS
·
Aug 03

Alnylam Pharmaceuticals Share Price Weakness Looks 'Overdone' Despite Softer Quarter, RBC Says

MT Newswires Live
·
Jul 31

RBC Cuts Price Target on Alnylam Pharmaceuticals to $350 From $445, Keeps Outperform Rating

MT Newswires Live
·
Jul 31

Analysts Conflicted on These Healthcare Names: Karyopharm Therapeutics (KPTI), Baxter International (BAX) and Alnylam Pharma (ALNY)

TIPRANKS
·
Jul 31

Alnylam price target lowered to $300 from $400 at Morgan Stanley

TIPRANKS
·
Jul 31

U.S. Research ROUNDUP-Apple, Amazon, Mastercard

Reuters
·
Jul 31

Alnylam Pharmaceuticals Inc : Needham Cuts Target Price to $357 from $510

THOMSON REUTERS
·
Jul 31

US Equity Markets End Higher on Microsoft's Cloud Gains, Semiconductor Rebound

MT Newswires Live
·
Jul 31

Neurocrine Biosciences Q2 Adjusted EPS Beats Expectations, Revenue Rises on Product Portfolio Growth

Reuters
·
Jul 31

Alnylam Pharmaceuticals is Maintained at Buy by Needham

Dow Jones
·
Jul 31

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-07-30

Reuters
·
Jul 31

Alnylam Lowers 2026 Outlook As Second-Line Amvuttra Demand Normalizes, Stock Tanks

Benzinga Earnings
·
Jul 31

Alnylam Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

Top Midday Decliners

MT Newswires Live
·
Jul 31

H.C. Wainwright Sticks to Their Buy Rating for Alnylam Pharma (ALNY)

TIPRANKS
·
Jul 31

Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC), Alnylam Pharma (ALNY) and Fortrea Holdings Inc. (FTRE)

TIPRANKS
·
Jul 31

U.S. Stocks on the MOVE-Mastercard, Starbucks, Meta

Reuters
·
Jul 30

Stock Track | Alnylam Pharmaceuticals Plummets 27.20% in Intraday Trading After Q2 Revenue Miss and Full-Year Guidance Cut

Stock Track
·
Jul 30